Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : UPCA - Uniprime Capital Acceptance, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Janice Shell who wrote (137)	7/21/1999 12:51:00 PM
From: im a survivor	Read Replies (1) \| Respond to of 640

Calls to the company's Las Vegas headquarters today were greeted by a recording explaining its voice mail was full. Jules Levin, executive director of the National AIDS Treatment Advocacy Project, which runs HIV treatment and education programs in minority communities in the New York City area, criticized the company's announcement. ``Any self-respecting researcher who has something that might help people with HIV should present it at a peer-reviewed medical meeting,' he said. ``I think they should be investigated for securities fraud.' Testimonials Letters from five patients allegedly treated with Plasma Plus were posted on Uniprime's Web site late yesterday. They were added to a section with auto salesmen's testimonials. ``I feel totally healed,' wrote Alfonso Valentin Salto Sanchez in a letter in Spanish and English. Uniprime said it ``received documentation from the government of Spain verifying the authenticity of the patients who have been treated' with Plasma Plus. The company, which owns auto dealerships in Rochester, New York, and Myrtle Beach, South Carolina, said it wouldn't release the documentation before getting a patent on Plasma Plus. ``Some people are going to think there is something to this and maybe try to take this and stop taking their medicines,' said Levin. ``It's very irresponsible.' 0- (STR) Jul/21/1999 11:32 EOS (STR) Jul/21/1999 11:32 197 Jul/21/1999 12:33 For more stories from Bloomberg News, click here. (C) Copyright 1999 Bloomberg L.P. Any redistribution of Bloomberg content, including by framing or similar means, is expressly prohibited without the prior written consent of Bloomberg L.P. Any reference to the material must be properly attributed to Bloomberg News. The information herein was obtained from sources which Bloomberg L.P. and its suppliers believe reliable, but they do not guarantee its accuracy. Neither the information, nor any opinion expressed, constitutes a solicitation of the purchase or sale of any securities or commodities.(C) Copyright 1999 Bloomberg L.P. BLOOMBERG, Bloomberg News, Bloomberg Financial Markets, Bloomberg Television, Bloomberg News Radio are trademarks, tradenames and service marks of Bloomberg L.P.